Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Oral Antibiotics Preferred for Pediatric Pneumonia

By Daniel Beris
Posted on 30 Nov 2016
Children with complicated pneumonia should be discharged from the hospital with oral instead of intravenous (IV) antibiotics when possible, according to a new study.

Researchers at Cincinnati Children's Hospital (OH, USA), the University of Pennsylvania (PA, USA), and other institutions conducted a multicenter retrospective cohort study of data from the Pediatric Health Information System (PHIS) to compare effectiveness and treatment-related complications of post-discharge antibiotics administered via a peripherally inserted central venous catheter (PICC), or administered orally. More...
The study included 2,123 children from 36 hospitals who received oral (1,842) and PICC (281) antibiotics that were discharged with complicated pneumonia between 2009 and 2012.

The results showed no significant differences in treatment failure rates between PICC and oral antibiotics. Conversely, children discharged with PICCs experienced a higher rate of infections, adverse drug reactions, and hospital readmissions, with PICC complications occurring in 7.1% of children who received intravenous antibiotics. In addition, 17.8% of the children who received IV antibiotics required unplanned or emergency care, compared with only 3.1% of children who received oral antibiotics. The study was published on November 17, 2016, in Pediatrics.

“Children with complicated pneumonia typically require prolonged antibiotic therapy, 2 to 4 weeks in total, much of which is administered after hospital discharge. Our study demonstrates that oral antibiotics are just as effective as intravenous antibiotics, but with fewer treatment-associated complications,” said lead author Samir Shah, MD, of Cincinnati Children's Hospital. “This means that most children with complicated pneumonia can safely be discharged with antibiotics by mouth, avoiding the pain and potential complications associated with PICC lines.”

“One other factor to consider is that some antibiotics such as vancomycin can only be given by PICC. It is possible that the higher rate of adverse drug reactions in the PICC group, such as drug fever or low blood counts, were related to type of antibiotic used, rather than how it was given,” concluded Dr. Shah. “The reality is that one should consider the higher rate of adverse drug reactions in the PICC group, regardless of the reason, as one more factor favoring the use of antibiotics by mouth for complicated pneumonia.”

Related Links:
Cincinnati Children's Hospital
University of Pennsylvania

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.